Hajdúch M - Search Results

1

[A retrospective analysis of trastuzumab-based therapy in metastatic breast cancer patients at Masaryk Memorial Cancer Institute. Identification of predictive factors].

Svoboda M, Grell P, Simícková M, Fabian P, Petráková K, Palácová M, Macková D, Trojanec R, Hajdúch M, Pavlík T, Nenutil R, Vyzula R. Svoboda M, et al. Among authors: hajduch m. Klin Onkol. 2008;21(6):348-58. Klin Onkol. 2008. PMID: 19382598 Czech.

2

[KRAS mutation testing in therapeutic algorithm for treatment of metastatic colorectal carcinoma].

Dubská L, Vyskocilová M, Nenutil R, Valík D, Knoflícková D, Fabian P, Kocáková I, Demlová R, Beránek M, Drastíková M, Vosmiková H, Bóday A, Horká K, Símová J, Drábek J, Ehrmann J, Hajdúch M, Matejcková M, Síma R, Tvrdík D, Povýsil C, Ryska A. Dubská L, et al. Among authors: hajduch m. Cas Lek Cesk. 2011;150(6):321-6. Cas Lek Cesk. 2011. PMID: 21751504 Review. Czech.

3

Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab.

Grell P, Fabian P, Khoylou M, Radova L, Slaby O, Hrstka R, Vyzula R, Hajduch M, Svoboda M. Grell P, et al. Among authors: hajduch m. Int J Oncol. 2012 Oct;41(4):1204-12. doi: 10.3892/ijo.2012.1576. Epub 2012 Jul 27. Int J Oncol. 2012. PMID: 22842582 Free PMC article.

4

Lapatinib in breast cancer - the predictive significance of HER1 (EGFR), HER2, PTEN and PIK3CA genes and lapatinib plasma level assessment.

Bouchalova K, Cizkova M, Cwiertka K, Trojanec R, Friedecky D, Hajduch M. Bouchalova K, et al. Among authors: hajduch m. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010 Dec;154(4):281-8. doi: 10.5507/bp.2010.043. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010. PMID: 21293538 Free article. Review.

5

BCL2 is an independent predictor of outcome in basal-like triple-negative breast cancers treated with adjuvant anthracycline-based chemotherapy.

Bouchalova K, Svoboda M, Kharaishvili G, Vrbkova J, Bouchal J, Trojanec R, Koudelakova V, Radova L, Cwiertka K, Hajduch M, Kolar Z. Bouchalova K, et al. Among authors: hajduch m. Tumour Biol. 2015 Jun;36(6):4243-52. doi: 10.1007/s13277-015-3061-7. Epub 2015 Jan 24. Tumour Biol. 2015. PMID: 25616695

6

Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients.

Kiss I, Mlcochova J, Bortlicek Z, Poprach A, Drabek J, Vychytilova-Faltejskova P, Svoboda M, Buchler T, Batko S, Ryska A, Hajduch M, Slaby O. Kiss I, et al. Among authors: hajduch m. Anticancer Res. 2016 Sep;36(9):4955-9. doi: 10.21873/anticanres.11063. Anticancer Res. 2016. PMID: 27630355 Clinical Trial.

7

Genetic Markers in Triple-Negative Breast Cancer.

Sporikova Z, Koudelakova V, Trojanec R, Hajduch M. Sporikova Z, et al. Among authors: hajduch m. Clin Breast Cancer. 2018 Oct;18(5):e841-e850. doi: 10.1016/j.clbc.2018.07.023. Epub 2018 Aug 4. Clin Breast Cancer. 2018. PMID: 30146351 Free article. Review.

8

Triple negative breast cancer--current status and prospective targeted treatment based on HER1 (EGFR), TOP2A and C-MYC gene assessment.

Bouchalova K, Cizkova M, Cwiertka K, Trojanec R, Hajduch M. Bouchalova K, et al. Among authors: hajduch m. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Mar;153(1):13-7. doi: 10.5507/bp.2009.002. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009. PMID: 19365520 Review.

9

Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer.

Bouchalová K, Trojanec R, Kolár Z, Cwiertka K, Cernáková I, Mihál V, Hajdúch M. Bouchalová K, et al. Among authors: hajduch m. Neoplasma. 2006;53(5):393-401. Neoplasma. 2006. PMID: 17013533

10

[What is the real importance of evaluating the expression of c-erbB-2 (HER-2/neu) in carcinoma of the breast and prostate? (A short review)].

Kolár Z, Dvorácková J, Plevová P, Student V, Hajdúch M, Trojanec R, Spacková K. Kolár Z, et al. Among authors: hajduch m. Cesk Patol. 2002;38 Suppl 1:15-9. Cesk Patol. 2002. PMID: 12677892 Review. Czech.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

385 results

Search Page

Filters